Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era-Reference-Cited by-同舟云学术

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era

Published:2017-09-20 Issue:12 Volume:49 Page:2143-2149
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Marchioni Michele^ORCID,Bandini Marco,Pompe Raisa S.,Tian Zhe,Martel Tristan,Kapoor Anil,Cindolo Luca,Berardinelli Francesco,Briganti Alberto,Shariat Shahrokh F.,Schips Luigi,Karakiewicz Pierre I.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/article/10.1007/s11255-017-1703-y/fulltext.html

Reference31 articles.

1. Motzer RJ, Bukowski RM (2006) Targeted therapy for metastatic renal cell carcinoma. J Clin Oncol 24(35):5601–5608. doi: 10.1200/JCO.2006.08.5415

2. Modi PK, Farber NJ, Singer EA (2016) Precision oncology: identifying predictive biomarkers for the treatment of metastatic renal cell carcinoma. Transl Cancer Res 5(Suppl 1):S76–S80. doi: 10.21037/tcr.2016.06.05

3. Choueiri TK, Escudier B, Powles T et al (2016) Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial. Lancet Oncol 17(7):917–927. doi: 10.1016/S1470-2045(16)30107-3

4. Hudes G, Carducci M, Tomczak P et al (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356(22):2271–2281. doi: 10.1056/NEJMoa066838

5. Motzer RJ, Escudier B, McDermott DF et al (2015) Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med 373(19):1803–1813. doi: 10.1056/NEJMoa1510665

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Cell Cancer – Insights in Drug Resistance Mechanisms;Anticancer Research;2023-11

2. Metastasis-directed treatment in kidney cancer;Current Opinion in Urology;2023-07-05

3. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival;Urologic Oncology: Seminars and Original Investigations;2023-02

4. Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity;World Journal of Urology;2022-10-12

5. The Distribution of Metastatic Renal Cell Carcinoma by Presenting Tumor Stage in the Modern Era;Clinical Genitourinary Cancer;2022-08